Current research status of tumor cell biomarker detection

Abstract

With the annual increases in the morbidity and mortality rates of tumors, the use of biomarkers for early diagnosis and real-time monitoring of tumor cells is of great importance. Biomarkers used for tumor cell detection in body fluids include circulating tumor cells, nucleic acids, protein markers, and extracellular vesicles. Among them, circulating tumor cells, circulating tumor DNA, and exosomes have high potential for the prediction, diagnosis, and prognosis of tumor diseases due to the large amount of valuable information on tumor characteristics and evolution; in addition, in situ monitoring of telomerase and miRNA in living cells has been the topic of extensive research to understand tumor development in real time. Various techniques, such as enzyme-linked immunosorbent assays, immunoblotting, and mass spectrometry, have been widely used for the detection of these markers. Among them, the detection of tumor cell markers in body fluids based on electrochemical biosensors and fluorescence signal analysis is highly preferred because of its high sensitivity, rapid detection and portable operation. Herein, we summarize recent research progress in the detection of tumor cell biomarkers in body fluids using electrochemical and fluorescence biosensors, outline the current research status of in situ fluorescence monitoring and the analysis of tumor markers in living cells, and discuss the technical challenges for their practical clinical application to provide a reference for the development of new tumor marker detection methods.

Recent Trends and Innovations in Bead-Based Biosensors for Cancer Detection

“…The subtle changes in biomarker levels characteristic of early stage cancer can be swiftly identified, contributing to improving patient outcomes. The combination of fast response and high sensitivity allows these biosensors to detect low-concentration biomarkers, reinforcing their role as powerful tools in early cancer diagnosis [33].…”

Electrochemical protein biosensors for disease marker detection: progress and opportunities

“…Biosensors have receptor and transducer functions and consist primarily of a molecular recognition element and a conversion element 2 , 3 . Compared to traditional commercial immunoassays such as enzyme-linked immunosorbent assay (ELISA) 4 , electrochemical biosensors offer advantages such as high sensitivity, rapid detection speed, low power consumption, and miniaturization 5 – 7 . Therefore, electrochemical biosensors are a current focus of research in the field of biological detection and analysis.…”

Oxygen Sensor-Guided Fine Needle Biopsy Studies of Human Cancer Xenografts in Mice

“…FNB uses a 20-gauge or smaller needle inserted into the suspected regions of tissue for extraction of a tissue sample for microscopic analysis. In many cancers, the biopsied cells can be further analyzed using immunohistochemistry, molecular studies of nucleic acids, and analysis of a variety of emerging biomarkers to determine the type of cancer and its response to particular therapies 2 . Needle placement can be assisted by ultrasound, X-ray stereotactic, or magnetic resonance imaging to more precisely locate contrasted suspect tissue.…”